The ratings of 10 Health Care Equipment & Supplies stocks are down this week, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
Entellus Medical, Inc. (ENTL) gets weaker ratings this week as last week’s C drops to a D. The company also gets F’s in return on equity. For more information, get Portfolio Grader’s complete analysis of ENTL stock.
Innocoll Holdings Plc’s (INNL) rating weakens this week, dropping to a D versus last week’s C. The company also gets F’s in earnings revisions, earnings surprise, and free cash flow. For more information, get Portfolio Grader’s complete analysis of INNL stock.
InVivo Therapeutics Corporation (NVIV) declines this week from a C to a D. The company also gets F’s in return on equity. For more information, get Portfolio Grader’s complete analysis of NVIV stock.
Accuray Incorporated (ARAY) slips from a C to a D this week. Accuray Incorporated designs, develops, and sells medical radiation systems for the treatment of tumors anywhere in the body. The company also gets F’s in return on equity. For more information, get Portfolio Grader’s complete analysis of ARAY stock.
Volitionrx Limited (VNRX) is having a tough week. The company’s rating falls from a C to a D. The company also gets F’s in return on equity. For more information, get Portfolio Grader’s complete analysis of VNRX stock.
This week, Cesca Therapeutics Inc.’s (KOOL) rating worsens to a F from the company’s D rating a week ago. Cesca Therapeutics Inc. designs, manufactures and markets automated and semi-automated devices and single-use processing disposables that enable hospitals and blood banks to manufacture a therapeutic dose of stem cells. The company also gets F’s in sales growth, earnings momentum, return on equity, and free cash flow. For more information, get Portfolio Grader’s complete analysis of KOOL stock.
Great Basin Scientific, Inc. (GBSN) earns a F this week, moving down from last week’s grade of D. The company also gets F’s in earnings momentum and free cash flow. For more information, get Portfolio Grader’s complete analysis of GBSN stock.
Slipping from a D to a F rating, OncoSec Medical Incorporated (ONCS) takes a hit this week. The company also gets F’s in return on equity and free cash flow. For more information, get Portfolio Grader’s complete analysis of ONCS stock.
This is a rough week for Corindus Vascular Robotics, Inc. (CVRS). The company’s rating falls to F from the previous week’s D. The company also gets F’s in return on equity and free cash flow. For more information, get Portfolio Grader’s complete analysis of CVRS stock.
This week, Amedica Corp. (AMDA) drops from a C to a D rating. The company also gets F’s in sales growth, earnings momentum, return on equity, and free cash flow. For more information, get Portfolio Grader’s complete analysis of AMDA stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.
